placebo), la mayora de ellos (liraglituda, semaglutida SC, dulaglutida, albiglutida y efpeglenatida) han demostrado adems una reduccin de los MACE respecto a placebo, mientras exenatida semanal o semaglutida oral mostraron una tendencia a reducir los MACE
Central nervous system engagement introduces risks of mood alteration, cognitive effects, and behavioral changes, necessitating careful dose titration and patient monitoring
In addition, Gcgr / mice developed steatosis when fed a high fat diet [54]
Additional experimental data support the protective role of GLP-1, including improved outcomes in DPP-4 knockout rats exposed to endotoxins and reduced mortality following GLP-1R activation ( Taken together, preclinical and clinical studies have demonstrated that GLP-1 receptor agonists exert pleiotropic effects extending beyond glycemic control, influencing multiple organ systems including the nervous, respiratory, hepatic, renal, cardiovascular, reproductive, and immune systems (Figure 4)
GHK-Cu copper peptide is also known as copper tripeptide and is a short-chain amino acid that is actually naturally occurring in the body
GSH is a reducing substrate of GPX4 activity, which is essential for preventing and inhibiting ferroptosis
